Severine Lacourt
About Severine Lacourt
Severine Lacourt is the Worldwide Commercialization Lead for Covid-neutralizing mAB at Bristol Myers Squibb, with extensive experience in global commercial leadership roles across the pharmaceutical industry.
Title and Current Position
Severine Lacourt currently holds the position of Worldwide Commercialization Lead for Covid-neutralizing mAB at BMS Rockefeller University. She is based in Princeton, New Jersey, United States, and works within Bristol Myers Squibb. In her role, she is responsible for driving the global commercialization strategy for Covid-neutralizing monoclonal antibodies, leveraging her extensive experience in product and portfolio management.
Past Roles at Bristol Myers Squibb
Severine Lacourt has held multiple roles at Bristol Myers Squibb over the years. From 2019 to 2021, she served as Chief of Staff to the CEO. Between 2018 and 2019, she was the Global Commercial Lead for biomarkers. Prior to that, from 2016 to 2017, she worked as the Worldwide Commercial Lead for Hematology. She also briefly held the position of Commercial Lead for Multiple Myeloma, Global Commercialization in 2016. Additionally, Severine was the Product & Portfolio Strategy Lead for China between 2014 and 2016, as well as the VP Commercialization Excellence & Strategic Planning Market Access China from 2013 to 2014. She also led the European integration of Amylin in 2012-2013.
Experience in Global Marketing
Severine Lacourt has significant experience in global marketing and strategy. She directed the global marketing strategy for Plavix at sanofi-aventis from 2006 to 2008, overseeing international campaigns. Prior to that role, she served as the Plavix Marketing Director in France from 2003 to 2006. Her experience also includes serving as a Group Marketing Manager for CNS at sanofi-aventis, as well as the Brand Manager for Stilnox in France.
Background in Strategic and Commercial Roles
In addition to her recent roles, Severine Lacourt has a background in strategic and commercial positions. She was the BU Director for Ethicon Women Health and Urology at Johnson & Johnson from 2008 to 2010. At GlaxoSmithKline (GSK), she worked as a Hospital Product Manager from 1999 to 2001, followed by a role as Strategic Projects Coordinator from 1998 to 1999. Her consulting experience includes working at The Boston Consulting Group from 1994 to 1996.
Educational Background
Severine Lacourt has an extensive educational background. She earned a Master's Degree in Entrepreneurship/Entrepreneurial Studies from HEC Paris, where she studied from 1989 to 1994. She also studied at ecole des hautes etudes commerciales from 1990 to 1994. Additionally, she achieved a Master of Business Administration (MBA) from INSEAD in a full-time one-year program in 1997.